The TP53 tumor suppressor and autophagy in malignant lymphoma

被引:13
|
作者
Xu-Monette, Zijun Y. [1 ]
Young, Ken H. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
关键词
autophagy; TP53; survival factor; prognosis; ULK1; EI24; SESN1; NUPR1; ERK; JNK;
D O I
10.4161/auto.19703
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The TP53 (p53) protein is a well-known tumor suppressor that plays a crucial role in maintaining genome stability under various cellular stresses. Loss of TP53 causes lymphomagenesis in mouse models and/or promotes tumor progression. However, the prognostic significance of TP53 has been inconsistent in human cancers including malignant lymphoma. In our recent review of TP53 dysfunction in lymphoid malignancies, we discussed the fact that the TP53 function in autophagy may be one of the important mechanisms responsible for the inconsistency of TP53 prognostic value, in that autophagy can promote survival of lymphoma cells by recycling toxic intracellular materials and inhibiting apoptosis. Here we discuss the biological mechanisms of TP53 functional switches from apoptosis to autophagy, and provide a brief summary of how TP53 regulates autophagy through its transcriptional activity on 14 genes of the TP53 pathway.
引用
收藏
页码:842 / 845
页数:4
相关论文
共 50 条
  • [1] Tumor-Suppressor Functions of the TP53 Pathway
    Aubrey, Brandon J.
    Strasser, Andreas
    Kelly, Gemma L.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2016, 6 (05):
  • [2] TP53, TP53 Target Genes (DRAM, TIGAR), and Autophagy
    Hu, Wanglai
    Chen, Song
    Thorne, Rick F.
    Wu, Mian
    AUTOPHAGY: BIOLOGY AND DISEASES: BASIC SCIENCE, 2019, 1206 : 127 - 149
  • [3] TP53 TUMOR-SUPPRESSOR GENE AND SKIN CARCINOGENESIS
    BASSETSEGUIN, N
    MOLES, JP
    MILS, V
    DEREURE, O
    GUILHOU, JJ
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 103 (05) : S102 - S106
  • [4] Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies
    Xu-Monette, Zijun Y.
    Medeiros, L. Jeffrey
    Li, Yong
    Orlowski, Robert Z.
    Andreeff, Michael
    Bueso-Ramos, Carlos E.
    Greiner, Timothy C.
    McDonnell, Timothy J.
    Young, Ken H.
    BLOOD, 2012, 119 (16) : 3668 - 3683
  • [5] TP53 TUMOR SUPPRESSOR GENE - A MODEL FOR INVESTIGATING HUMAN MUTAGENESIS
    DEFROMENTEL, CC
    SOUSSI, T
    GENES CHROMOSOMES & CANCER, 1992, 4 (01): : 1 - 15
  • [6] Genetic variations of the tumor suppressor TP53:: Outstanding and strategies of analysis
    Rangel-Lopez, Angelica
    Pina-Sanchez, Patricia
    Salcedo, Mauricio
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2006, 58 (03): : 254 - 264
  • [7] The tumor suppressor gene TP53: Implications for cancer management and therapy
    Seemann, S
    Maurici, D
    Olivier, M
    de Fromentel, CC
    Hainaut, P
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2004, 41 (5-6) : 551 - 583
  • [8] TP53 and RB tumor suppressor pathways collaborate in retinoblastoma genesis
    Ayrault, Olivier
    Zindy, Frederique
    Roussel, Martine F.
    M S-MEDECINE SCIENCES, 2007, 23 (04): : 356 - 358
  • [9] Tumor suppressor p53 (TP53) at the crossroads of the exposome and the cancer genome
    Schetter, Aaron J.
    Harris, Curtis C.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (21) : 7955 - 7956
  • [10] Trans-regulated silencing and reactivation of TP53 tumor suppressor gene in malignant transformation and its reversion
    Yang, LC
    Sasaki, MS
    JAPANESE JOURNAL OF CANCER RESEARCH, 2000, 91 (11): : 1111 - 1118